Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Renee Escalona"'
Autor:
Fatai S. Oladunni, Jun-Gyu Park, Paula A. Pino, Olga Gonzalez, Anwari Akhter, Anna Allué-Guardia, Angélica Olmo-Fontánez, Shalini Gautam, Andreu Garcia-Vilanova, Chengjin Ye, Kevin Chiem, Colwyn Headley, Varun Dwivedi, Laura M. Parodi, Kendra J. Alfson, Hilary M. Staples, Alyssa Schami, Juan I. Garcia, Alison Whigham, Roy Neal Platt, Michal Gazi, Jesse Martinez, Colin Chuba, Stephanie Earley, Oscar H. Rodriguez, Stephanie Davis Mdaki, Katrina N. Kavelish, Renee Escalona, Cory R. A. Hallam, Corbett Christie, Jean L. Patterson, Tim J. C. Anderson, Ricardo Carrion, Edward J. Dick, Shannan Hall-Ursone, Larry S. Schlesinger, Xavier Alvarez, Deepak Kaushal, Luis D. Giavedoni, Joanne Turner, Luis Martinez-Sobrido, Jordi B. Torrelles
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Here, the authors characterize tissue-level SARS-CoV-2 infection and pathogenesis in transgenic mice expressing human angiotensin converting enzyme 2 (hACE2) by the human cytokeratin 18 promoter (K18-hACE2) and show that infection induces lethality,
Externí odkaz:
https://doaj.org/article/36d6d32972464a4aafa1c9bc19844493
Autor:
Jun-Gyu Park, Fatai S. Oladunni, Mohammed A. Rohaim, Jayde Whittingham-Dowd, James Tollitt, Matthew D.J. Hodges, Nadin Fathallah, Muhsref Bakri Assas, Wafaa Alhazmi, Abdullah Almilaibary, Munir Iqbal, Pengxiang Chang, Renee Escalona, Vinay Shivanna, Jordi B. Torrelles, John J. Worthington, Lucy H. Jackson-Jones, Luis Martinez-Sobrido, Muhammad Munir
Publikováno v:
iScience, Vol 24, Iss 9, Pp 102941- (2021)
Summary: Global deployment of an effective and safe vaccine is necessary to curtail the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we evaluated a Newcastle disease virus (NDV)-bas
Externí odkaz:
https://doaj.org/article/8242157c2dd5466785ee86b3db0c87ec
Autor:
Rebecca A. Porritt, Carol Chase Huizar, Edward J. Dick, Shyamesh Kumar, Renee Escalona, Angela C. Gomez, Stefani Marek-Iannucci, Magali Noval Rivas, Jean Patterson, Thomas G. Forsthuber, Moshe Arditi, Mark Gorelik
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveKawasaki disease (KD) is the most common cause of acquired pediatric heart disease in the developed world. 10% of KD patients are resistant to front-line therapy, and no interventions exist to address secondary complications such as myocardi
Externí odkaz:
https://doaj.org/article/01b14a3efd3f4042a8c41acfc5780ac6
Autor:
John J. Worthington, Nadin Fathallah, Vinay Shivanna, Fatai S. Oladunni, Luis Martinez-Sobrido, Mohammed A. Rohaim, Lucy H. Jackson-Jones, Jun Gyu Park, Wafaa A. Alhazmi, Jordi B. Torrelles, Renee Escalona, Muhsref Bakri Assas, Pengxiang Chang, Muhammad Munir, Munir Iqbal, Matthew D. Hodges, Jayde Whittingham-Dowd, Abdullah Almilaibary, James Tollitt
Publikováno v:
iScience
iScience, Vol 24, Iss 9, Pp 102941-(2021)
iScience, Vol 24, Iss 9, Pp 102941-(2021)
Global deployment of an effective and safe vaccine is necessary to curtail the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we evaluated a Newcastle disease virus (NDV)-based vector
Autor:
Vinay Shivanna, Jun-Guy Park, James Tollitt, Lucy H. Jackson-Jones, Muhammad Munir, John J. Worthington, Mohammed A. Rohaim, Munir Iqbal, Fatai S. Oladunni, Wafaa A. Alhazmi, Jordi B. Torrelles, Bakri M. Assas, Pengxiang Chang, Renee Escalona, Luis Martinez-Sobrido, Jayde Whittingham-Dowd, Abdullah Almilaibary
The global deployment of an effective and safe vaccine is currently a public health priority to curtail the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we evaluated a Newc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efc64e3eca7c94871450e50b429a5147
https://doi.org/10.1101/2021.01.08.425974
https://doi.org/10.1101/2021.01.08.425974
Autor:
Andreu Garcia-Vilanova, Corbett Christie, Edward J. Dick, Jordi B. Torrelles, Hilary M. Staples, Kendra J. Alfson, Luis D. Giavedoni, Jun-Gyu Park, Tim J. Anderson, Kevin Chiem, Olga Gonzalez, Juan Ignacio García, Larry S. Schlesinger, Laura M. Parodi, Jean L. Patterson, Varun Dwivedi, Deepak Kaushal, Shannan Hall-Ursone, Colin Chuba, Ricardo Carrion, Chengjin Ye, Katrina N. Kavelish, Angélica Olmo-Fontánez, Stephanie Earley, Luis Martinez-Sobrido, Xavier Alvarez, Cory R. A. Hallam, Stephanie Davis Mdaki, Anna Allué-Guardia, Roy N. Platt, Renee Escalona, Paula A. Pino, Alyssa Schami, Colwyn A. Headley, Michal Gazi, Jesse Martinez, Shalini Gautam, Oscar H. Rodriguez, Fatai S. Oladunni, Joanne Turner, Alison Whigham, Anwari Akhter
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease would benefit from validated small animal models. Here, we show that transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) by the human cytokeratin
Autor:
Shannan Hall-Ursone, Luis D. Giavedoni, Jun-Gyu Park, Anwari Akhter, Olga Gonzalez, Deepak Kaushal, Colin Chuba, Stephanie Earley, Colwyn A. Headley, Anna Allué-Guardia, Andreu Garcia-Vilanova, Alyssa Schami, Katrina N. Kavelish, Luis Martinez-Sobrido, Michal Gazi, Edward J. Dick, Jesse Martinez, Stephanie Davis Mdaki, Chengjin Ye, Cory R. A. Hallam, Jean L. Patterson, Fatai S. Oladunni, Joanne Turner, Tim J. Anderson, Kevin Chiem, Paula Pino Tamayo, Xavier Alvarez, Laura M. Parodi, Kendra J. Alfson, Jordi B. Torrelles, Roy N. Platt, Renee Escalona, Hilary M. Staples, Juan Ignacio García, Alison Whigham, Larry S. Schlesinger, Shalini Gautam, Angélica Olmo-Fontánez, Oscar H. Rodriguez, Varun Dwivedi, Ricardo Carrion, Corbett Christie
Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease currently lacks a validated small animal model. Here, we show that transgenic mice expressing human angiotensin converting enzyme 2 (hACE2) by the human cytokeratin 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa50cf7872db4bc56d6bc609bb2581ec
https://doi.org/10.1101/2020.07.18.210179
https://doi.org/10.1101/2020.07.18.210179
Autor:
Hareesh B. Nair, Michael A. Owston, Robert Baker, Klaus J. Nickisch, John L. VandeBerg, Renee Escalona, Edward J. Dick
Publikováno v:
Oncotarget
// Hareesh B. Nair 1 , Robert Baker 2 , Michael A. Owston 2 , Renee Escalona 2 , Edward J. Dick 2 , John L. VandeBerg 2 and Klaus J. Nickisch 1 1 Evestra, Inc., San Antonio, TX, USA 2 Southwest National Primate Research Center, Texas Biomedical Resea